Search

everythinglearnresearchcommunity

for

Search:↓

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

The Ewha Medical Journal is now in PubMed, has an AI article editor, and offers Korean reporting guidelines.

"Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Using L-PRF membranes for skull base surgery might help healing, but more research is needed.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Using electronic health records can help identify drug side effects but has some limitations.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Platelet-rich plasma (PRP) shows promise for treating melasma but needs more research for confirmation.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Some supplements may help with hair loss, but there's not enough strong evidence to recommend them without doctor advice.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

The treatment showed promising hair regrowth in advanced-stage hair loss.